ClinicalTrials.gov reporting gap draws FDA compliance push
The agency sent messages tied to more than 3,000 registered trials that appear to lack required results information on ClinicalTrials.gov.
The U.S. Food and Drug Administration has reminded more than 2,200 medical product companies and researchers to submit required clinical trial results information to ClinicalTrials.gov.
According to FDA, 29.6% of studies highly likely to fall under mandatory reporting requirements have no results information submitted to the federal database.
Mandatory reporting applies to interventional studies with a U.S. nexus and an FDA-regulated product that are past the deadline to report. Phase 1 studies and device feasibility studies are excluded, the agency said.
On March 30, FDA sent messages to companies and researchers associated with more than 3,000 registered clinical trials. Some of those trials were publicly funded.
Agency messages targeted trials that do not appear to have submitted required results information or may not have completed the National Library of Medicine’s quality-control review process. FDA said the messages seek voluntary compliance.
Clinical trial sponsors and researchers are generally required to submit results information to ClinicalTrials.gov 1 year after trial completion, FDA said. ClinicalTrials.gov lists the standard results submission deadline as within 1 year of the completion date.
FDA said it may also send pre-notices of noncompliance and notices of noncompliance as part of risk-based compliance efforts related to ClinicalTrials.gov.
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
Richmond radiology practice reports 266K-record breach
Radiology Associates of Richmond said an unauthorized actor accessed its network in July 2025, with notification letters sent to affected individuals starting May 21, 2026.
Lumexa Imaging reports vendor-related data incident
A vendor incident may have exposed patient identifiers, insurance information, diagnoses, visit dates, and other radiology-related health information tied to Lumexa-affiliated practices.
MOC-linked radiation oncology care associated with lower Medicare costs
A retrospective Medicare Part B analysis found that radiation oncologists voluntarily participating in ABR maintenance of certification used more advanced techniques and had 10.31% lower Medicare costs per treatment course.
MARCA bill revives Medicare hospital claims for radiologist assistants
The Medicare Access to Radiology Care Act would allow radiologists to submit Medicare claims for nondiagnostic services performed by radiologist assistants under direct supervision in hospital and office settings.
House committee advances Medicare physician payment reform bill
The Provider Reimbursement Stability Act of 2026 would limit annual Medicare conversion-factor changes to ±2.5% and raise the budget-neutrality threshold.
International Focused Ultrasound Society launches
The new society will focus on clinical adoption, training, credentialing, coding, billing, clinical guidelines, patient advocacy, and industry partnerships.
AMA issues patient guidance on safe healthcare chatbot use
AMA released patient-facing prompts and cautions for health AI chatbot use, saying AI should supplement, not replace, physician expertise.
RANT projects $51M in No Surprises Act admin costs
Radiology Associates of North Texas said current batching rules and unpaid IDR awards could create more than $51M in avoidable administrative costs.
ACR issues guidance for breast biopsy needle shortage
The guidance offers triage, conservation, inventory, case-prioritization, and patient-communication strategies for practices affected by the stereotactic breast biopsy needle shortage.
USC names Joshua Hirsch chair of radiology
Hirsch joins Keck School of Medicine of USC from Massachusetts General Hospital and Harvard Medical School, bringing experience in neurointervention, health policy, quality, and clinical operations.
Saphier nomination leaves surgeon general duties with HHS deputy
Stephanie Haridopolos will assume some surgeon general duties while radiologist Nicole Saphier awaits Senate confirmation.
Budget-neutrality bill draws radiology group support
ACR, SIR, ASNR, and other physician groups urged Congress to pass H.R. 8163, the Provider Reimbursement Stability Act.